(Q37676970)

21 August 2017

1 reference

title

Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function (English)

1 reference

21 August 2017

Klaus Dittmann

1

1 reference

21 August 2017

Claus Mayer

series ordinal

2

1 reference

21 August 2017

H Peter Rodemann

series ordinal

3

1 reference

21 August 2017

publication date

28 December 2009

1 reference

Strahlentherapie und Onkologie

21 August 2017

published in

1 reference

21 August 2017

volume

186

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

1-6

1 reference

Growth of intestinal epithelium in organ culture is dependent on EGF signalling

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Search for heavy long-lived particles that decay to photons at CDF II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

1,25-Dihydroxyvitamin D down-regulates cell membrane growth- and nuclear growth-promoting signals by the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Radiation-induced caveolin-1 associated EGFR internalization is linked with nuclear EGFR transport and activation of DNA-PK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Extracellular heat shock protein 70 mediates heat stress-induced epidermal growth factor receptor transactivation in A431 carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Co-regulation of B-Myb expression by E2F1 and EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Biology of interactions: antiepidermal growth factor receptor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Out of breath, asleep at the wheel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Mechanisms of DNA double strand break repair and chromosome aberration formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Epidermal growth factor receptor exposed to oxidative stress undergoes Src- and caveolin-1-dependent perinuclear trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Cetuximab/C225-induced intracellular trafficking of epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Nuclear localization of EGF receptor and its potential new role as a transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Molecular targeted treatment and radiation therapy for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

The multiple faces of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Anti-epidermal growth factor receptor monotherapy in the treatment of metastatic colorectal cancer: where are we today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Radiation-induced EGFR-signaling and control of DNA-damage repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Differential activation of epidermal growth factor (EGF) receptor downstream signaling pathways by betacellulin and EGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Combination of EGFR/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Identification of EGF receptor C-terminal sequences 1005-1017 and di-leucine motif 1010LL1011 as essential in EGF receptor endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Tyrosine phosphorylation controls PCNA function through protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Protein translocation across biological membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

Validation of HB-EGF and amphiregulin as targets for human cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00066-009-2026-4

An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).

21 January 2018

1 reference

12 December 2020

Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells

1 reference

12 December 2020

Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors

1 reference

12 December 2020

Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer.

1 reference

12 December 2020

Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents

1 reference

12 December 2020

Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity.

1 reference

12 December 2020

In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody

1 reference

12 December 2020

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma

1 reference

12 December 2020

The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment

1 reference

12 December 2020

High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis

1 reference

12 December 2020

Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer

1 reference

12 December 2020

10.1007/S00066-009-2026-4

Identifiers

DOI

1 reference

21 August 2017

1 reference